These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

242 related articles for article (PubMed ID: 25203888)

  • 41. Intestinal alkaline phosphatase inhibits the proinflammatory nucleotide uridine diphosphate.
    Moss AK; Hamarneh SR; Mohamed MM; Ramasamy S; Yammine H; Patel P; Kaliannan K; Alam SN; Muhammad N; Moaven O; Teshager A; Malo NS; Narisawa S; Millán JL; Warren HS; Hohmann E; Malo MS; Hodin RA
    Am J Physiol Gastrointest Liver Physiol; 2013 Mar; 304(6):G597-604. PubMed ID: 23306083
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Intestinal alkaline phosphatase promotes gut bacterial growth by reducing the concentration of luminal nucleotide triphosphates.
    Malo MS; Moaven O; Muhammad N; Biswas B; Alam SN; Economopoulos KP; Gul SS; Hamarneh SR; Malo NS; Teshager A; Mohamed MM; Tao Q; Narisawa S; Millán JL; Hohmann EL; Warren HS; Robson SC; Hodin RA
    Am J Physiol Gastrointest Liver Physiol; 2014 May; 306(10):G826-38. PubMed ID: 24722905
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Interplay between intestinal alkaline phosphatase, diet, gut microbes and immunity.
    Estaki M; DeCoffe D; Gibson DL
    World J Gastroenterol; 2014 Nov; 20(42):15650-6. PubMed ID: 25400448
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Role of alkaline phosphatase in colitis in man and rats.
    Tuin A; Poelstra K; de Jager-Krikken A; Bok L; Raaben W; Velders MP; Dijkstra G
    Gut; 2009 Mar; 58(3):379-87. PubMed ID: 18852260
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Jinzhi protects lipopolysaccharide-treated mice against mortality by repairing intestinal mucosal barrier damage and intestinal microecology.
    Xu J; Song J; Zhang Y; Wang Y; Yang L; Sha Y; Sun B; You N; Tian X; Lin R; Wu Y
    Biomed Pharmacother; 2020 Mar; 123():109749. PubMed ID: 31846840
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Cyclooxygenase-2 deficiency leads to intestinal barrier dysfunction and increased mortality during polymicrobial sepsis.
    Fredenburgh LE; Velandia MM; Ma J; Olszak T; Cernadas M; Englert JA; Chung SW; Liu X; Begay C; Padera RF; Blumberg RS; Walsh SR; Baron RM; Perrella MA
    J Immunol; 2011 Nov; 187(10):5255-67. PubMed ID: 21967897
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Enteral access and intestinal function assessment in the critically ill patient].
    Mesejo A; Juan M; García-Simón M
    Nutr Hosp; 2007 May; 22 Suppl 2():37-49. PubMed ID: 17679292
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Intestinal alkaline phosphatase at the crossroad of intestinal health and disease - a putative role in type 1 diabetes.
    Lassenius MI; Fogarty CL; Blaut M; Haimila K; Riittinen L; Paju A; Kirveskari J; Järvelä J; Ahola AJ; Gordin D; Härma MA; Kumar A; Hamarneh SR; Hodin RA; Sorsa T; Tervahartiala T; Hörkkö S; Pussinen PJ; Forsblom C; Jauhiainen M; Taskinen MR; Groop PH; Lehto M;
    J Intern Med; 2017 Jun; 281(6):586-600. PubMed ID: 28393441
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The In Vitro Protective Role of Bovine Lactoferrin on Intestinal Epithelial Barrier.
    Zhao X; Xu XX; Liu Y; Xi EZ; An JJ; Tabys D; Liu N
    Molecules; 2019 Jan; 24(1):. PubMed ID: 30609730
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Inhibition of the gut enzyme intestinal alkaline phosphatase may explain how aspartame promotes glucose intolerance and obesity in mice.
    Gul SS; Hamilton AR; Munoz AR; Phupitakphol T; Liu W; Hyoju SK; Economopoulos KP; Morrison S; Hu D; Zhang W; Gharedaghi MH; Huo H; Hamarneh SR; Hodin RA
    Appl Physiol Nutr Metab; 2017 Jan; 42(1):77-83. PubMed ID: 27997218
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Low doses of celecoxib attenuate gut barrier failure during experimental peritonitis.
    Short SS; Wang J; Castle SL; Fernandez GE; Smiley N; Zobel M; Pontarelli EM; Papillon SC; Grishin AV; Ford HR
    Lab Invest; 2013 Dec; 93(12):1265-75. PubMed ID: 24126890
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The effect of intestinal alkaline phosphatase on intestinal epithelial cells, macrophages and chronic colitis in mice.
    Lee C; Chun J; Hwang SW; Kang SJ; Im JP; Kim JS
    Life Sci; 2014 Apr; 100(2):118-124. PubMed ID: 24548630
    [TBL] [Abstract][Full Text] [Related]  

  • 53. 27-Hydroxycholesterol contributes to cognitive deficits in APP/PS1 transgenic mice through microbiota dysbiosis and intestinal barrier dysfunction.
    Wang Y; An Y; Ma W; Yu H; Lu Y; Zhang X; Wang Y; Liu W; Wang T; Xiao R
    J Neuroinflammation; 2020 Jun; 17(1):199. PubMed ID: 32593306
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Gut barrier in the critically ill patient: facts and trends].
    Velasco N
    Rev Med Chil; 2006 Aug; 134(8):1033-9. PubMed ID: 17130993
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Faecalibacterium prausnitzii-derived microbial anti-inflammatory molecule regulates intestinal integrity in diabetes mellitus mice via modulating tight junction protein expression.
    Xu J; Liang R; Zhang W; Tian K; Li J; Chen X; Yu T; Chen Q
    J Diabetes; 2020 Mar; 12(3):224-236. PubMed ID: 31503404
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Prevention of antibiotic-associated metabolic syndrome in mice by intestinal alkaline phosphatase.
    Economopoulos KP; Ward NL; Phillips CD; Teshager A; Patel P; Mohamed MM; Hakimian S; Cox SB; Ahmed R; Moaven O; Kaliannan K; Alam SN; Haller JF; Goldstein AM; Bhan AK; Malo MS; Hodin RA
    Diabetes Obes Metab; 2016 May; 18(5):519-27. PubMed ID: 26876427
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Change in intestinal alkaline phosphatase activity is a hallmark of antibiotic-induced intestinal dysbiosis.
    Dissanayake WMN; Chandanee MR; Lee SM; Heo JM; Yi YJ
    Anim Biosci; 2023 Sep; 36(9):1403-1413. PubMed ID: 37170509
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Oral supplementation with non-absorbable antibiotics or curcumin attenuates western diet-induced atherosclerosis and glucose intolerance in LDLR-/- mice--role of intestinal permeability and macrophage activation.
    Ghosh SS; Bie J; Wang J; Ghosh S
    PLoS One; 2014; 9(9):e108577. PubMed ID: 25251395
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Intestinal HIF-1α deletion exacerbates alcoholic liver disease by inducing intestinal dysbiosis and barrier dysfunction.
    Shao T; Zhao C; Li F; Gu Z; Liu L; Zhang L; Wang Y; He L; Liu Y; Liu Q; Chen Y; Donde H; Wang R; Jala VR; Barve S; Chen SY; Zhang X; Chen Y; McClain CJ; Feng W
    J Hepatol; 2018 Oct; 69(4):886-895. PubMed ID: 29803899
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Luminal epidermal growth factor preserves mucosal mass of small bowel in fasting rats.
    Ulshen MH; Raasch RH
    Clin Sci (Lond); 1996 May; 90(5):427-31. PubMed ID: 8665781
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.